Microsensor player to present concept study with IoT platform at MD&M West

Sensor manufacturer Sensirion and pump technology specialist Quantex will be presenting a concept study in the field of infusion technology at this year’s MD&M West.

It will focus on Quantex’s new wearable drug delivery IoT platform ‘Quantex 4C’. It will feature Sensirion’s LD20 single-use liquid flow sensor which measures flow rates in the micro and milliliter per hour range with the help of CMOSens Technology

Additionally, it features sensitive failure detection mechanisms to help counteract, for example, occlusions and air-in-line. The pump design from Quantex is based on a rotary, fixed displacement principle to make it less sensitive to variables such as line pressure, fluid viscosity and flow rate.

‘Quantex 4C’ integrates connectivity with a modular drug delivery platform and enables continuous monitoring of the therapy with the help of a single use liquid flow sensor for safe ambulatory treatments.

Paul Pankhurst, founder and CEO of Quantex said: “Real time bidirectional flow verification at the low flow rates that are typical for the targeted application and the sensor’s compact form factor made the Sensirion LD20 single-use liquid flow sensor the ideal choice.”

The objective of the study is to demonstrate the possibilities of a comprehensive drug delivery system to the medical technology industry. The compactness, low power consumption and cost-effectiveness of both, sensor and pump, allow the design of a wearable device which controls and monitors the drug delivery therapy simultaneously. The platform could open up entirely new possibilities for all involved stakeholders. While patients and clinicians benefit from an increased ease of use and confidence in the therapy, low maintenance and less training efforts; it allows healthcare and pharma companies to capture vital adherence data and simplifies patient compliance.

Reliable failure detection is a central requirement for next generation drug delivery devices. Ambulatory treatments and wearable applications will only be successful if patients as well as clinicians trust the reliability of those next generation devices.

MD&M West takes place from 5-7 February at Anaheim Convention Center, California.